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Abstract
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Induction of HIF-1α by oxygen limitation promotes increased phosphorylation and catalytic
depression of mitochondrial pyruvate dehydrogenase (PDH) and an enhanced glycolytic poise in
cells. Cobalt chloride and desferrioxamine are widely used as mimics for hypoxia because they
increase the levels of HIF-1α. We evaluated the ability of these agents to elicit selected
physiological responses to hypoxia as a means to metabolically precondition mammalian cells, but
without the detrimental effects of hypoxia. We show that while CoCl2 does increase HIF-1α in a
dose-dependent manner, it unexpectedly and strikingly decreases PDH phosphorylation at E1α
sites 1, 2, and 3 (Ser293, Ser300, and Ser232 respectively) in HepG2 cells. This same effect is also
observed for site 1 in mouse NIH/3T3 fibroblasts and J774 macrophages. CoCl2 unexpectedly
decreases the mRNA expression for PDH kinase-2 in HepG2 cells, which likely explains the
dephosphorylation of PDH observed. Desferrioxamine does not promote the expected increase in
PDH phosphorylation either. Dimethyloxaloylglycine (a prolyl hydroxylase inhibitor) performs
better in this regard, but failed to promote the stronger effects seen with hypoxia. Consequently,
CoCl2 and desferrioxamine are unreliable mimics of hypoxia for physiological events downstream
of HIF-1α stabilization. Our study demonstrates that mimetic chemicals must be chosen with
caution and evaluated thoroughly if bona fide cellular outcomes are to be promoted with fidelity.
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Introduction
The metabolic preconditioning of mammalian tissue has become a significant topic of
research in recent years (Menze et al. 2005; Gohil et al. 2010; Halestrap 2010; Menze et al.
2010; Gohil et al. 2011; Hand et al. 2011a). For example, the physiological response to
hypoxia has been shown to have beneficial effects for biostabilization during ischemic
recovery (Alchera et al. 2010; Hyvärinen et al. 2010; Semenza 2011; Eckle et al. 2012;
Sarkar et al. 2012). However, exposure to natural hypoxia can result in harmful oxidative
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stress and reduced viability in most mammalian cells. Therefore, in lieu of true oxygen
limitation, artificial alternatives that induce a bona fide physiological hypoxic response
would be desirable. For some time it has been suggested that CoCl2 may act as an artificial
mimic of hypoxia (Goldwasser et al. 1958; Goldberg et al. 1987; Goldberg et al. 1988; Bunn
and Poyton 1996). CoCl2 may replace the necessary ferrous iron of prolyl hydroxylase
(PHD) and prevent it from targeting hypoxia inducible factor-1α (HIF-1α; Semenza and
Wang 1992) for proteasomal degradation (Ivan et al. 2001; Jaakkola et al. 2001).
Consequently, CoCl2 has been used as an artificial stabilizer of HIF-1α (Wang and Semenza
1993a; Wang and Semenza 1993b; Pugh et al. 1997; Kim et al. 2006). During the natural
state of hypoxia, oxygen limitation (and/or an associated elevation of reactive oxygen
species (Brunelle et al. 2005; Guzy et al. 2005; Semenza 2007; Kaelin and Ratcliffe 2008;
Ježek et al. 2010) inactivates PHD, and the cellular concentrations of HIF-1α increase (Jiang
et al. 1996; Ivan et al. 2001; Jaakkola et al. 2001; Semenza 2007; Kaelin and Ratcliffe 2008;
Ježek et al. 2010). HIF-1 then promotes expression of numerous downstream target genes,
including those whose products phosphorylate and downregulate the activity of the pyruvate
dehydrogenase complex (PDC) (Kim et al. 2006; Papandreou et al. 2006; Semenza 2007; Lu
et al. 2008). Although CoCl2 does increase the cellular levels of HIF-1α, the downstream
effects of this commonly-utilized mimic of hypoxia have been incompletely evaluated.
Because inhibition of PDC is key to the depression of mitochondrial oxidative metabolism
under hypoxia (Kim et al. 2006; Papandreou et al. 2006; Ježek et al. 2010), it is important
that CoCl2 elicits a comparable increase in PDC phosphorylation in order to emulate
hypoxia in a physiologically-valid manner. Thus we evaluate herein the impact of three
reported PHD inhibitors [CoCl2, desferrioxamine, dimethyloxaloylglycine (DMOG)] on
HIF-1α stabilization and PDC phosphorylation in three mammalian cell lines.
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The PDC is strongly regulated by the phosphorylation and de-phosphorylation of its
pyruvate dehydrogenase (PDH) component, also known simply as E1 (Korotchkina and
Patel 2001; Harris et al. 2002). In humans, there are four isozymes of the pyruvate
dehydrogenase kinase (PDK1-4) and two isozymes of the pyruvate dehydrogenase
phosphatase (PDP1-2), which are integral components of the PDC and are synthesized in a
tissue-dependent manner (Bowker-Kinley et al. 1998; Korotchkina and Patel 2001; Harris et
al. 2002; Kim et al. 2006; Papandreou et al. 2006). PDH is an α2β2 tetramer, and there are
three phosphorylation sites on the α subunit: Ser293, Ser300, and Ser232 (sites 1, 2, and 3,
respectively) (Korotchkina and Patel 2001). These sites are differentially affected by the
different isoforms of PDK and PDP, but phosphorylation at any of these sites will lower
PDC activity (Korotchkina and Patel 2001).
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We show that CoCl2, desferrioxamine, and DMOG all increase HIF-1α to varying degrees.
However, in contrast to hypoxia, CoCl2 promotes a marked decrease in PDH
phosphorylation in all three cell lines tested -- human HepG2 hepatoma cells, NIH/3T3
mouse fibroblasts, and J774 mouse macrophages. Enhancement of PDH phosphorylation
was minimal at best with desferrioxamine even though it also elevated HIF-1α. DMOG
increased phosphorylation for all 3 sites in HepG2 cells, but not to the extent seen with
hypoxia. CoCl2 and desferrioxamine do not serve as reliable mimics of hypoxia in terms of
their influence on some targets downstream of HIF-1, and thus should be used with caution
if bona fide physiological impacts are desired beyond HIF-1α stabilization.

Materials and methods
Cell culture
All three cell lines were obtained from ATCC (Manassas, VA, USA). HepG2 human
hepatoma cells, NIH/3T3 mouse fibroblasts, and J774 mouse macrophages were maintained
in Gibco Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum
Cell Tissue Res. Author manuscript; available in PMC 2014 January 01.
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(FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, and 2 mM glutamine (all from
Invitrogen, Carlsbad, CA, USA). Cells were grown to 70% confluence in 75 cm2 tissue
culture flasks (Celltreat, Shirley, MA, USA) and maintained in a humidified atmosphere of 5
% CO2-95 % air at 37°C. For experiments, cells were detached using 0.25% trypsin-EDTA
solution (Invitrogen, Carlsbad, CA, USA) and seeded at 1–3 × 106 cells/plate. The number
of cells was determined by counting with a hemocytometer (Hausser and Son, Philadelphia,
PA, USA).
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For hypoxia studies, cell culture dishes were transferred to a modular incubator chamber
(Model MIC-101; Billups-Rothenberg, Del Mar, CA, USA) and exposed to a gas mixture
composed of 1% oxygen, 5% carbon dioxide and 94% nitrogen (premixed gas obtained from
Airgas Southwest, The Woodlands, TX, USA). The chamber containing culture plates was
flushed with the above gas mixture for 30 min at a flow rate of 9.5 L/min and incubated for
3 h at 37° C to allow equilibration of culture medium with the gas phase. The chamber was
flushed again for 30 min and then the cells incubated for 21 h at 37° C. For CoCl2 and
desferrioxamine studies, cells were exposed to the indicated concentrations for 24 h at 37°
C.
Western blotting

$watermark-text
$watermark-text

Treated cells were harvested directly in SDS-PAGE buffer (Laemmli) composed of 62.5
mmol·l−1 Tris-HCl pH 6.8, 2% SDS, 25% glycerol, and 5% β-mercaptoethanol. Protein
concentrations were quantified using Pierce 660 nm reagent with the ionic detergent
compatibility reagent added per the manufacturer’s instructions (Thermo Fisher Scientific,
Rockford, IL, USA). Samples were heat denatured for 1 min at 96°C in sample buffer and
fractionated by SDS-PAGE with 8% polyacrylamide gels using a Mini Protein 3 gel
apparatus (Bio-Rad, Hercules, CA, USA) at 125 V for 1 h followed by 175 V for 15 min.
After SDS-PAGE, proteins were electrophoretically transferred to nitrocellulose (0.2 μm
Trans-Blot; Bio-Rad) using a Bio-Rad Mini Trans-Blot transfer cell (80 V for 1 h at <18°C).
Blots were blocked with a solution of 5% fat-free dry milk in Tris-buffered saline (TBS-T;
50 mM Tris-base, 150 mM NaCl, 0.05% Tween-20, pH 7.6 with HCl) and then incubated
overnight with a primary antibody at 4° C. Antibodies used were monoclonal anti-HIF-1α
(BD Transduction Laboratories, Sparks, MD), polyclonal PhosphoDetect Anti-PDH-E1α
(pSer293), Anti-PDH-E1α (pSer300) and Anti-PDH-E1α (pSer232) (Merck KGaA,
Darmstadt, Germany), and polyclonal anti-β-actin (Cell Signaling Technology, Danvers,
MA). Blots were subsequently washed in TBS-T and incubated for 1 h with the appropriate
species-specific secondary IgG HRP-linked antibodies (Cell Signaling Technology) and
visualized with Lumiglo chemiluminescent reagent (Cell Signaling Technology). All
blotting procedures were performed at 22–23°C. Image J software (National Institutes of
Health, Bethesda, MD, USA) was used for quantification of Western blot images.
PCR and rtqPCR
RNA was isolated using an RNeasy Mini kit (Qiagen, Valencia, CA, USA) as per the
manufacturer’s instructions for animal cells. cDNA was synthesized using a DyNAmo
cDNA synthesis kit (New England Biolabs, Ipswich, MA, USA).
PCR analysis was performed using a GeneAmp PCR System 9700 (Applied Biosystems,
Carlsbad, CA, USA) and Crimson Taq DNA polymerase mix (New England Biolabs,
Ipswich, MA, USA) as per manufacturer’s instructions. In brief, the reaction mixture
contained 1X Crimson Taq reactions buffer, 200 μM dNTPs, 0.5 μM each primer, template
cDNA, 1.25 units Taq and was brought to a final volume of 50 μl with nuclease-free H2O.
Cycling parameters were 5 min of denaturation at 95 °C, and then 30 cycles of a two-step
protocol (95 °C, 30 s; 63 °C, 30 s), followed by a 10 min final extension step at 72 °C. PCR
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products were visualized with ethidium bromide after agarose gel electrophoresis (1.5%
SeaKem LE Agarose gel; Lonza, Rockland, ME, USA).
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rtqPCR analysis was performed with an ABI Prism 7000 (Applied Biosystems, Carlsbad,
CA, USA) and SYBR Green master mix (SA Biosciences, Frederick, MD, USA) with a total
reaction volume of 25 μl. Cycling parameters were 10 min at 95 °C and then 40 cycles of 95
°C (15 s) and 60 °C (60 s) followed by a melting curve analysis. Each treatment was
evaluated with nine independent experiments, each with three nested replicates, and with
reference dye normalization. The cycle threshold (Ct) value was determined with the
manufacturer’s software. After determination of the PCR efficiencies (Pfaffl 2001), all Ct
values were normalized to the expression of a bona fide housekeeping gene, β-actin. The
PCR primers used to identify human PDK-2 were 5′-AGCCAGTTCACTGACGCCCTG-3′
and 5′-GGAGAATGAGGCTGGACTCAT-3′. To yield a smaller product optimized for
rtqPCR, primers for PDK-2 were 5′-TCATCAACCAGCACACCCTCATCT-3′ and 5′ACTTGTCACACAGGAGCTTAGCCA-3′. The primers used for human β-actin were 5′GGCACCCAGCACAATGAAGATCAA-3′ and 5′ACTCGTCATACTCCTGCTTGCTGA-3′.
Statistical Analyses
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One-way ANOVA was performed using SAS v9.1 (SAS Institute, Cary, NC, USA).
Assumptions of normality and homogeneity of variance were met, and a Tukey-Kramer
adjustment was used for multiple pair-wise comparisons of means. Nine separate tests were
performed, each comprised of three nested replicates for each sample. Each experimental
treatment was compared to the control in order to obtain the percent change (Pfaffl 2001).
Values are expressed as mean ± standard deviation (S.D.). Statistical analysis of Western
blot quantification was performed with Graphpad InStat (Graphpad Software, La Jolla, CA,
USA). p ≤ 0.05 was considered significant.

Results and discussion
CoCl2 decreases phosphorylation of pyruvate dehydrogenase in HepG2 cells
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CoCl2 is frequently used as a stabilizing agent for HIF-1α because it inhibits the prolyl
hydroxylase responsible for signaling HIF-1α degradation (Ivan et al. 2001; Jaakkola et al.
2001). Predictably, CoCl2 increased the levels of HIF-1α in a dose-dependent manner in
HepG2 cells when incubated for 24 h (Fig. 1). These results are consistent with those of
Wang and Semenza (Wang and Semenza 1993b) for HeLa and Hep3B cells and Pugh et al.
(Pugh et al. 1997) for Hep3B cells. However, contrary to expectations, CoCl2 strongly
decreased the phosphorylation state of PDH at site 1 (α subunit of E1, phosphoserine293)
(Fig. 1). This unexpected result was readily observed at the low concentration of 100 μM
CoCl2 after only 8 h of incubation time (Fig. 2a). At 500 μM CoCl2 and above there was no
detectable phosphorylation at site 1. Similar results with CoCl2 were obtained for the
phosphorylation of PDH at site 2 (α subunit of E1, phosphoserine300) and site 3 (α subunit
of E1, phosphoserine232). Phosphorylation at both of these sites decreased noticeably at 50–
250 μM CoCl2 with the phosphorylation at both sites completely disappearing by 500 μM
CoCl2 (Fig. 1).
As expected, exposure of HepG2 cells to hypoxia [1% oxygen; pO2 approximately 0.95 kPa
or 7.1 mm Hg (torr)] for 24 h increased the levels of HIF-1α compared to normoxic controls
(Fig. 1), although not to the extent seen with low concentrations of CoCl2. Also as expected,
hypoxia increased the phosphorylation of PDH at sites 1, 2 and 3 compared to normoxic
controls (Fig. 1).
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CoCl2 decreases phosphorylation of E1α in NIH/3T3 fibroblasts and J774 macrophages
In order to test whether or not the CoCl2 effect on HepG2 cells was cell-line specific, NIH/
3T3 mouse fibroblasts and J774 mouse macrophages were exposed to CoCl2 for 24 h. The
viability of these fibroblasts and macrophages was significantly reduced at CoCl2
concentrations above 300 μM and 150 μM, respectively, and thus exposures used were
lowered accordingly. Nevertheless, just as in the HepG2 cells, both NIH/3T3 (Fig. 2b) and
J774 cells (Fig. 2c) showed a significant decrease in the phosphorylation of site 1, but at
even lower concentrations (25 μM CoCl2).

$watermark-text

Desferrioxamine and DMOG increase HIF-1α but desferrioxamine has little effect on PDH
phosphorylation in HepG2 cells
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Desferrioxamine is an iron chelator that likely inhibits PHD in a similar fashion as CoCl2,
eliminating the functionally-necessary ferrous iron of PHD, thereby stabilizing HIF-1α
(Wang and Semenza 1993a; Pugh et al. 1997; Ivan et al. 2001; Jaakkola et al. 2001). DMOG
is membrane-permeable competitive inhibitor of PHD (Jaakkola et al. 2001). In order to test
whether the CoCl2 effect on PDH was specific to that compound, HepG2 cells were
incubated with desferrioxamine or DMOG for 24 h. As expected, both desferrioxamine and
DMOG increased the levels of HIF-1α in a dose-dependent manner, and desferrioxamine
increased the levels of HIF-1α above that seen with hypoxia, similar to CoCl2 (Fig. 3). But
in contrast to expectations, desferrioxamine did not increase the phosphorylation of PDH at
site 1 or site 3, and only marginally increased site 2 phosphorylation even in the face of
strongly elevated HIF-1α (Fig. 3a). DMOG, meanwhile, did increase phosphorylation of all
3 sites, although it did not elevate the levels of HIF-1α to the extent of CoCl2 or
desferrioxamine (Fig. 3b). DMOG did not increase the phosphorylation of all 3 sites to the
degree that hypoxia did, but the levels of HIF-1α were also lower than under hypoxia (Fig.
3b). Thus while CoCl2 and desferrioxamine increased HIF-1α, neither of these compounds
promoted the anticipated increase in PDH phosphorylation, and CoCl2 actually decreased it.
DMOG did elevate HIF-1α and PDH phosphorylation to a degree, but failed to promote the
stronger effects seen with the natural state of hypoxia (Fig. 3b). Quantification of the
Western blots illustrates the influence on HIF-1α and the phosphorylation state of PDH of
CoCl2 and desferrioxamine (Fig. 4) and DMOG (Fig. 5). Taken together, our results indicate
that CoCl2 and desferrioxamine are unreliable mimics of hypoxia for events downstream of
HIF-1α.
CoCl2 reduces mRNA expression of PDK-2
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We predicted that the decrease in PDH phosphorylation observed when cells were incubated
with CoCl2 was promoted by a decrease in the synthesis of PDK-2, the most abundant PDK
isoform in liver cells (Bowker-Kinley et al. 1998; Korotchkina and Patel 2001). We tested
this hypothesis qualitatively using PCR and found that mRNA for PDK-2 in HepG2 cells
did appear to decrease when the cells were incubated with CoCl2, while cells exposed to 24
h of hypoxia showed little difference in mRNA compared to normoxic controls (Fig. 6a).
mRNA for PDK-1 and PDK-4 did not differ in cells incubated with CoCl2 versus untreated
controls or cells exposed to hypoxia, and PDK-3 mRNA increased in both hypoxic cells and
CoCl2-treated cells, as expected (data not shown). We used rtqPCR analysis to confirm that
PDK-2 mRNA quantitatively declined in response to CoCl2 exposure. At concentrations of
250 μM CoCl2 and above, PDK-2 mRNA exhibited a statistically significant drop of 65–
80% compared to untreated control cells (Fig. 6b). PDK-2 mRNA expression was
normalized to the mRNA of a housekeeper gene (β-actin).
Thus, CoCl2 may have decreased PDH phosphorylation by decreasing the expression of
PDK-2 mRNA (Fig. 6). A drop in the amount of PDK-2 would disrupt the balance between
this kinase and PDH phosphatase, thereby lowering the steady-state phosphorylation of
Cell Tissue Res. Author manuscript; available in PMC 2014 January 01.

Borcar et al.

Page 6

$watermark-text

PDH. The effect of CoCl2 on PDK-2 is surprising because previous work has shown that
when HIF-1α is stabilized by hypoxia the expression of PDK-1 and PDK-3 mRNA
increases (Kim et al. 2006; Papandreou et al. 2006; Semenza 2007; Lu et al. 2008). Due to
our interest in HepG2 cells, PDK-2 was investigated in the present study because of its
prominence in liver tissue (Bowker-Kinley et al. 1998; Korotchkina and Patel 2001).
Information regarding the hypoxia responsiveness of PDK-2 is very limited, but it is
appropriate to note that Lu et al. (Lu et al. 2008) reported a low-scoring HRE associated
with the PDK-2 gene. They observed no increase in expression of PDK-2 mRNA after
exposure to hypoxia, a result they conjectured was due to cell type (HeLa cells). In this
study we showed that hypoxia does not increase the PDK-2 mRNA level in HepG2 cells.
Thus the increased levels of PDH phosphorylation observed under hypoxia are likely the
result of increased PDK-3 synthesis, based upon the unchanged expression of PDK-1 and
PDK-4 mRNA under hypoxia mentioned above for HepG2 cells.
Concluding remarks
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Adaptation to hypoxia in mammalian cells has become an important topic in cancer research
and metabolic preconditioning in many tissues and organs. Some cancers utilize the cellular
hypoxia response within the tumor microenvironment when rapid cell growth has outpaced
adequate vascularization and even afterwards to keep mitochondrial activity low (Vander
Heiden et al. 2009; Ježek et al. 2010; Semenza 2010; Jose et al. 2011). The response to
hypoxia in mammalian cells commonly involves the depression of mitochondrial oxidative
phosphorylation and enhanced glycolytic poise. We originally intended to increase levels of
HIF-1α with CoCl2 (or desferrioxamine, DMOG) in order to test the hypothesis that
fostering such a shift in metabolic poise would precondition mammalian cells (Menze et al.
2005; Menze et al. 2010; Hand et al. 2011a; Semenza 2011) for increased survivorship
during biostabilization by cryopreservation and desiccation (Menze et al. 2010; Hand et al.
2011b). However, the major observation of this study is the unexpected and prominent
decrease in PDH phosphorylation when cells are incubated with CoCl2 compared to the
increase in PDH phosphorylation under hypoxia despite the significant increase of HIF-1α
in both cases. We surmise that the cause of this decrease is the significantly lower levels of
PDK-2 transcription for cells incubated with CoCl2 compared to those under hypoxia. The
mechanism behind the surprising impact of CoCl2 on PDK-2 expression is as yet unknown
and warrants further study. But it is clear from our results that CoCl2 is a poor choice to
artificially mimic hypoxia in HepG2, NIH/3T3, and J774 cell lines for selected events
downstream of HIF-1α stabilization. Similarly, we also show that desferrioxamine does not
promote the expected increase in PDH phosphorylation levels seen under hypoxia in HepG2
cells, making it an unsuitable mimic of hypoxia as well. While it does increase HIF-1α and
PDH phosphorylation, DMOG was significantly less effective than hypoxia. The
observations reported in this paper emphasize the diligence required when attempts are
made to artificially stimulate a physiological state with drugs that actually may promote
unwanted, divergent effects or have little or no impact.

Acknowledgments
This study was supported by National Institutes of Health [2-RO1-DK046270-14A1]. The authors would like to
thank Benjamin Adams from the Department of Entomology at Louisiana State University for his help in
performing statistical analyses.

References
Alchera E, Dal Ponte C, Imarisio C, Albano E, Carini R. Molecular mechanisms of liver
preconditioning. World J Gastroenterol. 2010; 16:6058–6067. [PubMed: 21182220]

Cell Tissue Res. Author manuscript; available in PMC 2014 January 01.

Borcar et al.

Page 7

$watermark-text
$watermark-text
$watermark-text

Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM. Evidence for existence of tissuespecific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J. 1998; 329:191–
196. [PubMed: 9405293]
Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, Scarpulla RC, Chandel NS.
Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005;
1:409–414. [PubMed: 16054090]
Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev. 1996;
76:839–885. [PubMed: 8757790]
Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, Lowes BD, Han J, Borchers
CH, Buttrick PM, Kominsky DJ, Colgan SP, Eltzschig HK. Adora2b-elicited per2 stabilization
promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat
Med. 2012; 18:774–782. [PubMed: 22504483]
Gohil VM, Offner N, Walker JA, Sheth SA, Fossale E, Gusella JF, MacDonald ME, Neri C, Mootha
VK. Meclizine is neuroprotective in models of Huntington’s disease. Hum Mol Genet. 2011;
20:294–300. [PubMed: 20977989]
Gohil VM, Sheth SA, Nilsson R, Wojtovich AP, Lee JH, Perocchi F, Chen W, Clish CB, Ayata C,
Brookes PS, Mootha VK. Nutrient-sensitized screening for drugs that shift energy metabolism from
mitochondrial respiration to glycolysis. Nat Biotech. 2010; 28:249–255.
Goldberg M, Dunning S, Bunn H. Regulation of the erythropoietin gene: Evidence that the oxygen
sensor is a heme protein. Science. 1988; 242:1412–1415. [PubMed: 2849206]
Goldberg MA, Glass GA, Cunningham JM, Bunn HF. The regulated expression of erythropoietin by
two human hepatoma cell lines. Proc Natl Acad Sci USA. 1987; 84:7972–7976. [PubMed:
2825172]
Goldwasser E, Jacobson LO, Fried W, Plzak LF. Studies on erythropoiesis: V. The effect of cobalt on
the production of erythropoietin. Blood. 1958; 13:55–60. [PubMed: 13499580]
Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker
PT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular
oxygen sensing. Cell Metab. 2005; 1:401–408. [PubMed: 16054089]
Halestrap AP. A pore way to die: The role of mitochondria in reperfusion injury and cardioprotection.
Biochem Soc Trans. 2010; 38:841–860. [PubMed: 20658967]
Hand SC, Menze MA, Borcar A, Patil Y, Covi JA, Reynolds JA, Toner M. Metabolic restructuring
during energy-limited states: Insights from Artemia franciscana embryos and other animals. J
Insect Physiol. 2011a; 57:584–594. [PubMed: 21335009]
Hand SC, Menze MA, Toner M, Boswell L, Moore D. LEA proteins during water stress: Not just for
plants anymore. Annu Rev Physiol. 2011b; 73:115–134. [PubMed: 21034219]
Harris RA, Bowker-Kinley MM, Huang B, Wu P. Regulation of the activity of the pyruvate
dehydrogenase complex. Adv Enzyme Regul. 2002; 42:249–259. [PubMed: 12123719]
Hyvärinen J, Hassinen IE, Sormunen R, Mäki JM, Kivirikko KI, Koivunen P, Myllyharju J. Hearts of
hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute
ischemia-reperfusion injury. J Biol Chem. 2010; 285:13646–13657. [PubMed: 20185832]
Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr.
HIFα targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2
sensing. Science. 2001; 292:464–468. [PubMed: 11292862]
Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim Av, Hebestreit HF,
Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-α to the von
Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;
292:468–472. [PubMed: 11292861]
Ježek P, Plecitá-Hlavatá L, Smolková K, Rossignol R. Distinctions and similarities of cell
bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Int J
Biochem Cell Biol. 2010; 42:604–622. [PubMed: 19931409]
Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over
a physiologically relevant range of O2 tension. Am J Physiol. 1996; 271:C1172–C1180. [PubMed:
8897823]

Cell Tissue Res. Author manuscript; available in PMC 2014 January 01.

Borcar et al.

Page 8

$watermark-text
$watermark-text
$watermark-text

Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: A
tumor’s dilemma? Biochim Biophys Acta. 2011; 1807:552–561. [PubMed: 20955683]
Kaelin WG, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the HIF hydroxylase
pathway. Mol Cell. 2008; 30:393–402. [PubMed: 18498744]
Kim, J-w; Tchernyshyov, I.; Semenza, GL.; Dang, CV. HIF-1-mediated expression of pyruvate
dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab.
2006; 3:177–185. [PubMed: 16517405]
Korotchkina LG, Patel MS. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward
the three phosphorylation sites of human pyruvate dehydrogenase. J Biol Chem. 2001; 276:37223–
37229. [PubMed: 11486000]
Lu C-W, Lin S-C, Chen K-F, Lai Y-Y, Tsai S-J. Induction of pyruvate dehydrogenase kinase-3 by
hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem. 2008;
283:28106–28114. [PubMed: 18718909]
Menze MA, Chakraborty N, Clavenna M, Banerjee M, Liu X-H, Toner M, Hand SC. Metabolic
preconditioning of cells with AICAR-riboside: Improved cryopreservation and cell-type specific
impacts on energetics and proliferation. Cryobiology. 2010; 61:79–88. [PubMed: 20510224]
Menze MA, Clavenna MJ, Hand SC. Depression of cell metabolism and proliferation by membranepermeable and -impermeable modulators: Role for AMP-to-ATP ratio. Am J Physiol Regul Integr
Comp Physiol. 2005; 288:R501–R510. [PubMed: 15458972]
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by
actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006; 3:187–197.
[PubMed: 16517406]
Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic
Acids Res. 2001; 29:2002–2007.
Pugh CW, O’Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. Activation of hypoxia-inducible factor-1;
definition of regulatory domains within the α subunit. J Biol Chem. 1997; 272:11205–11214.
[PubMed: 9111021]
Sarkar K, Cai Z, Gupta R, Parajuli N, Fox-Talbot K, Darshan MS, Gonzalez FJ, Semenza GL.
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase
cardioprotection induced by ischemic preconditioning. Proc Natl Acad Sci USA. 2012;
109:10504–10509. [PubMed: 22699503]
Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor
1. Biochem J. 2007; 405:1–9. [PubMed: 17555402]
Semenza GL. HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;
20:51–56. [PubMed: 19942427]
Semenza GL. Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of
ischemic preconditioning. Biochim Biophys Acta. 2011; 1813:1263–1268. [PubMed: 20732359]
Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to
the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell
Biol. 1992; 12:5447–5454. [PubMed: 1448077]
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic
requirements of cell proliferation. Science. 2009; 324:1029–1033. [PubMed: 19460998]
Wang G, Semenza G. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible
factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood.
1993a; 82:3610–3615. [PubMed: 8260699]
Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response
to hypoxia. Proc Natl Acad Sci USA. 1993b; 90:4304–4308. [PubMed: 8387214]

Cell Tissue Res. Author manuscript; available in PMC 2014 January 01.

Borcar et al.

Page 9

$watermark-text
Fig. 1.
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Western blot analysis of HepG2 cells that were incubated with the indicated concentrations
of CoCl2 or exposed to hypoxia (“H”; 1% O2) for 24 h. Amounts of HIF-1α, the
phosphorylation state of PDH site 1 (E1α subunit, phosphoserine293), site 2 (E1α subunit,
phosphoserine300), site 3 (E1α subunit, phosphoserine232), and the β-actin loading control
are shown.
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Fig. 2.
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a Western blot analysis of the effect of 100 μM CoCl2 on HepG2 cells across the indicated
time course. Amounts of HIF-1α, the phosphorylation state of PDH site 1 (E1α subunit,
phosphoserine293) and the β-actin loading control are shown. b Western blot analysis of
NIH/3T3 fibroblasts that were incubated with the indicated concentrations of CoCl2 or
exposed to hypoxia (“H”; 1% O2) for 24 h. The phosphorylation state of PDH site 1 (E1α
subunit, phosphoserine293) and β-actin loading control are indicated. c Western blot analysis
of J774 macrophages that were incubated with the indicated concentrations of CoCl2 or
exposed to hypoxia (“H”; 1% O2) for 24 h. The phosphorylation state of PDH site 1 (E1α
subunit, phosphoserine293) and β-actin loading control are shown.
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Fig. 3.
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a Western blot analysis of HepG2 cells that were incubated with the indicated
concentrations of desferrioxamine or exposed to hypoxia (“H”; 1% O2) for 24 h. Amounts of
HIF-1α, the phosphorylation state of PDH site 1 (E1α subunit, phosphoserine293), site 2
(E1α subunit, phosphoserine300), site 3 (E1α subunit, phosphoserine232) and the β-actin
loading control are documented. b Western blot analysis of HepG2 cells that were incubated
with the indicated concentrations of DMOG or exposed to hypoxia (“H”; 1% O2) for 24 h.
Amounts of HIF-1α, the phosphorylation state of PDH site 1 (E1α subunit,
phosphoserine293), site 2 (E1α subunit, phosphoserine300), site 3 (E1α subunit,
phosphoserine232) and the β-actin loading control are shown.
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Quantitative impact of 24 h incubations of HepG2 cells with CoCl2 (solid lines) and
desferrioxamine (dashed lines) on the phosphorylation states of PDH site 1 (closed circles),
site 2 (closed squares) and site 3 (closed triangles). All values are normalized to β-actin.
Slopes of the linear regressions for sites 1 and 3 were not significantly different from zero (p
> 0.05) for the HepG2 cells incubated with desferrioxamine, while the small positive slope
for site 2 was significantly different from zero (p = 0.013). Inset: Elevation of HIF-1α
(normalized to β-actin) in HepG2 cells after 24 h exposures to CoCl2 (open circles) and
desferrioxamine (open squares).
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Fig. 5.

Quantification of Western blots illustrates the impact of 24 h incubation with DMOG on the
phosphorylation states of PDH site 1 (circles), site 2 (squares) and site 3 (triangles) in
HepG2 cells. All values are normalized to β-actin. Inset: Elevation of HIF-1α (normalized
to β-actin) in HepG2 cells after 24 h exposures to DMOG.
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Fig. 6.

Expression of PDK-2 mRNA in HepG2 cells that were incubated with the indicated
concentrations of CoCl2 or exposed to hypoxia (“H”; 1% O2) for 24 h. a PCR analyses of
mRNA for PDK-2 and β-actin (loading control) are shown. b Results obtained by rtqPCR.
PDK-2 mRNA was normalized to a housekeeper gene (β-actin mRNA) and expressed as a
percentage of the untreated/normoxic control. Asterisks indicate significant differences from
the hypoxia treatment (“H”) (one-way ANOVA, n = 9, mean ± 1 SD; p ≤ 0.05).
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